{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:15:40Z","timestamp":1791231340283,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.euroneuro.2014.11.022","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T21:32:24Z","timestamp":1418247144000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Capillary compared to venous blood sampling in clozapine treatment: patients\u05f3 and healthcare practitioners\u05f3 experiences with a point-of-care device"],"prefix":"10.1016","volume":"25","author":[{"given":"Jan P.A.M.","family":"Bogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martien","family":"Herruer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.11.022_bib1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4088\/JCP.11r06977","article-title":"Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy","volume":"73","author":"Cohen","year":"2012","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib2","unstructured":"European Medicines Agency (EMA), 2002. Committee for proprietary medicinal products (CPMP): summary information on referral opinion following arbitration pursuant to article 30 of council directive 2001\/83\/EC for Leponex and associated names. \u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Leponex_30\/WC500010966.pdf\u3009 (accessed 13.05.14.)."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib3","unstructured":"Food and Drug Administration (FDA), 2002. Clozaril. \u3008http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2002\/19758se1-047_Clozaril_lbl.pdf\u3009 (accessed 13.05.14.)."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1176\/appi.ps.002022012","article-title":"Antipsychotic prescribing pathways, polypharmacy, and clozapine use in the treatment of schizophrenia","volume":"64","author":"G\u00f6ren","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Brit. J. Psychiat."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia \u2013 the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists\u05f3 attitude towards and knowledge of clozapine treatment","volume":"24","author":"Nielsen","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.euroneuro.2011.10.001","article-title":"Hematological clozapinemonitoring with a point-of-care device: a randomized cross-over trial","volume":"22","author":"Nielsen","year":"2012","journal-title":"Eur. Neuropsychopharm."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson","year":"1999","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1176\/appi.ps.201300180","article-title":"Geographic and clinical variation in clozapine use in the United States","volume":"65","author":"Stroup","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2014.11.022_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10597-007-9089-4","article-title":"FACT: a Dutch version of ACT","volume":"43","author":"Van Veldhuizen","year":"2007","journal-title":"J. Commun. Ment. Health"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T15:46:38Z","timestamp":1690731998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0924977X14003332"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.022","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capillary compared to venous blood sampling in clozapine treatment: patients\u05f3 and healthcare practitioners\u05f3 experiences with a point-of-care device","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}